Co-Authors
This is a "connection" page, showing publications co-authored by Lila Bouadma and Bruno Lina.
Connection Strength
0.170
-
An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-ß-1a and hydroxychloroquine in hospitalized patients with COVID-19. Clin Microbiol Infect. 2021 Dec; 27(12):1826-1837.
Score: 0.059
-
France's COVID-19 response: balancing conflicting public health traditions. Lancet. 2020 07 25; 396(10246):219-221.
Score: 0.056
-
Clinical and virological data of the first cases of COVID-19 in Europe: a case series. Lancet Infect Dis. 2020 06; 20(6):697-706.
Score: 0.055